Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Corbus Pharmaceuticals Q3 EPS $(0.07) Down From $(0.02) YoY

Corbus Pharmaceuticals (NASDAQ:CRBP) reported quarterly losses of $(0.07) per share. This is a 250 percent decrease over losses of $(0.02) per share from the same period last year.
byBenzinga Newsdesk
November 8, 2022
1 minute read
Total
0
Shares
0
0
0
0
0
0

Corbus Pharmaceuticals (NASDAQ:CRBP) reported quarterly losses of $(0.07) per share. This is a 250 percent decrease over losses of $(0.02) per share from the same period last year.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

Tesla Analysts Size Up Ugly Q1 Numbers: Disaster, Train Wreck, Horror Show, Nightmare — Will Storm Pass Or Are Darker Days Ahead?

By Adam Eckert
April 2, 11:54 AM
Tesla posted its first year-over-year decline in deliveries since 2020 on Tuesday, which sparked a selloff in shares. The EV maker said the decline in volumes was partially due to the production ramp of the updated Model 3, as well as factory shutdowns resulting from the Red Sea conflict and an arson attack at its German gigafactory.

TSLA